On June 25, 2026, Dallah Healthcare Company announced the results of its Ordinary General Assembly Meeting held on June 24, 2026, at 7:15 PM in Riyadh via modern technology with 72.37% shareholder attendance. The assembly approved the appointment of KPMG Al Fozan & Partners as external auditor for fiscal year 2026 and Q1 2027 with fees of SAR 4,015,880 excluding VAT. Key approvals included authorization of various related-party transactions totaling millions in SAR, including a share purchase agreement worth SAR 497,983,407 and multiple service agreements ranging from SAR 9,737 to SAR 8,404,215. The meeting also authorized the Board of Directors to distribute interim dividends for fiscal year 2027 and delegated General Assembly powers to the Board for one year.

Original announcement:

Important Notice: The announcement information and market data in this report are sourced directly from the Saudi Exchange (Tadawul). This summary is generated by Sahm’s proprietary AI model for informational purposes only. While we strive for accuracy, it should not be construed as financial advice or an investment recommendation.